TTrialPathMatch Me to Trials
← Back to trials
RecruitingVestibular Migraine

Acute Treatment of Vestibular Migraine by Rimegepant

Eligible age

18–60 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

To evaluate whether rimegepant improves acute vestibular symptoms and accompanying discomforts in patients with vestibular migraine.

Sponsor: Wensheng Qu

You may qualify if…

  • ✓ 1. Age 18-60 years, male or female.
  • ✓ 2. Diagnosis of vestibular migraine according to the Bárány Society criteria.
  • ✓ 3. ≥4 episodes of characteristic vestibular symptoms in the past year, each of moderate to severe intensity and lasting \>2 hours (without intervention).
  • ✓ 4. Signed informed consent obtained from the participant.

You may not qualify if…

  • ✕ 1. Presence of other disorders causing acute vestibular symptoms (e.g., Ménière's disease, otitis media).
  • ✕ 2. Coexisting non-vertiginous dizziness (e.g., dizziness due to panic disorder), unless the patient can clearly distinguish these episodes from vestibular-migraine attacks.
  • ✕ 3. Severe hepatic dysfunction (ALT and/or AST \>3× upper limit of normal) or renal impairment (creatinine clearance \<30 mL/min).
  • ✕ 4. Severe cardiovascular or cerebrovascular disease.
  • ✕ 5. Alcohol abuse or substance abuse.
  • ✕ 6. Known pregnancy or lactation, or a positive pregnancy test prior to randomization.
  • ✕ 7. Contraindication or hypersensitivity to any medications used in the study.
  • ✕ 8. Initiation or dose adjustment of any preventive migraine therapy within 3 months prior to study drug administration.

Source: ClinicalTrials.gov · NCT07871097 · last updated 2026-10-13